Search Within

Angela Rose Brannon

Formats
  1. Meeting Abstract (56)
  2. Journal Article (40)
  3. Research Letter (3)
Groups
  1. Department of Pathology and Laboratory Medicine (99)
  2. GSK Faculty (92)
  3. Human Oncology and Pathogenesis Program (92)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (82)
  5. Department of Medicine (64)
  6. Solid Tumor Oncology Division (57)

More Groups

People
  1. Michael Berger (78)
  2. Marc Ladanyi (43)
  3. Maria Arcila (42)
  4. David Solit (30)
  5. Nikolaus Schultz (26)
  6. Ahmet Zehir (24)

More People

Years
  1. 2025 (5)
  2. 2024 (21)
  3. 2023 (15)
  4. 2022 (14)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Journal of Molecular Diagnostics (10)
  3. Cancer Research (8)
  4. Modern Pathology (7)
  5. Clinical Cancer Research (6)
  6. Laboratory Investigation (6)

More Publications

Publishers
  1. American Association for Cancer Research (19)
  2. American Society of Clinical Oncology (16)
  3. Nature Publishing Group (16)
  4. Elsevier Science, Inc. (12)
  5. Nature Research (7)
  6. Oxford University Press (7)

More Publishers

Results (99)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and genomic landscape of FGFR3-altered urothelial carcinoma and treatment outcomes with erdafitinib: A real-world experience
    Journal Article

    Guercio, B. J.; Sarfaty, M.; Teo, M. Y.; Ratna, N.; Duzgol, C.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Regazzi, A. M.; Chen, Z.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Allele-specific loss or mutations in CDKN2A/B worsen overall survival in IDH-mutant astrocytomas
    Meeting Abstract

    Hickman, R.; Gedvilaite, E.; Ptashkin, R.; Cimera, R.; Vanderbilt, C.; Benhamida, J.; Fahy, T.; Young, R.; Miller, A.; Mellinghoff, I.; more...
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save
  • IDH-mutant astrocytomas with primitive neuronal component are aggressive tumors characterized by alterations in RB1 and TP53
    Meeting Abstract

    Slocum, C.; Hickman, R.; Gedvilaite, E.; Ptashkin, R.; Brannon, R.; Ladanyi, M.; Miller, A.; Pentsova, E.; Tabar, V.; Young, R.; more...
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save
  • Institutional experience of routine genomic profiling of cell-free DNA from cerebrospinal fluid across a wide range of malignancies
    Meeting Abstract

    Hickman, R.; Miller, A.; Jee, J.; Liu, S.; Pentsova, E.; Holle, B.; Ross, D.; Nandakumar, S.; Vanderbilt, C.; Rana, S.; more...
    Journal of Neuropathology and Experimental Neurology (2023)

    Fulltext@MSK | Save
  • Validation of an ultra-sensitive genomic NGS assay for hematological malignancies
    Meeting Abstract

    DiNapoli, S. E.; Gedvilaite, E.; Bowman, A.; Xu, F.; Parikh, A. D.; Diosdado, M.; Cassanova-Murphy, J.; Rana, S.; Haque, M. H.; Hale, C.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Allele-specific CDKN2A/B loss worsens overall survival in IDH-mutant astrocytomas
    Meeting Abstract

    Hickman, R. A.; Gedvilaite, E.; Ptashkin, R.; Cimera, R.; Vanderbilt, C.; Benhamida, J.; Fahy, T.; Young, R.; Miller, A.; Mellinghoff, I.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)
    Meeting Abstract

    Keane, F.; Saadat, L.; O'Connor, C.; Chou, J. F.; Brannon, A. R.; Cowzer, D.; Crowley, F.; Debnath, N.; Bowman, A.; Xu, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Cell free DNA (cfDNA) assessment of esophagogastric (EG) cancer using MSK-ACCESS
    Meeting Abstract

    Cytryn, S. L.; Solit, D. B.; Walch, H. S.; Chatila, W. K.; Maron, S. B.; Vakiani, E.; Brannon, A. R.; Ladanyi, M.; Schultz, N.; Berger, M. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • MYC amplification segment-size mutual exclusivity analysis with other oncogenic events in a pan-cancer sequencing cohort
    Meeting Abstract

    Repetto, M.; Richards, A. L.; Chen, M. F.; Zhu, Y.; Selenica, P.; Gazzo, A.; Lee, P.; Price, A.; Yang, S. R.; Marra, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Quantifying the growth of clinical actionability in precision oncology using OncoKB
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Nandakumar, S.; Nissan, M. H.; Zhang, H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Carrero, S.; Arcila, M. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save